1. Other Lab Equipment For Sale
  2. sku: 18788705295786611
  3. ATRICURE CGG100

ATRICURE CGG100 Atriclip Laa Exclusion AOD0

Cgg100 Atricure Atriclip Laa Exclusion System - Selection Guide Aod0 Exp 2024

( Brand: Atricure ), ( Manufacturer Part Number: CGG100 ), ( Part Type: Guide ), ( Unit Type: Unit ), ( Instrument: Exclusion System ), ( Country/region Of Manufacture: United States )

Review ATRICURE Atriclip Laa Exclusion System Selection Guide Exp

The Atricure CGG100 Atriclip LAA Exclusion AOD 2024 is a medical device designed for the minimally invasive treatment of atrial fibrillation (AFib), a common heart rhythm disorder. This specific model is part of the Atriclip LAA Exclusion System, which utilizes a clip-based mechanism to isolate the left atrial appendage (LAA), a structure in the heart that is often involved in the formation of blood clots in patients with AFib.

The Atricure CGG100 Atriclip is a self-expanding, nitinol clip with a pre-attached, shaped, and secured polyester occluder. It is designed to be delivered via a transseptal approach, allowing for percutaneous closure of the LAA without the need for open heart surgery. The clip's shape conforms to the natural anatomy of the LAA, ensuring a secure and effective seal.

The AOD 2024 is the delivery system for the CGG100 Atriclip. It is a flexible, steerable, and repositionable sheath that facilitates the delivery and deployment of the clip. The sheath is equipped with a detachable distal tip, which can be used to navigate the complex anatomy of the heart and gain access to the LAA. Once the clip is deployed, the sheath can be removed, leaving the clip in place to seal off the LAA.

The Atricure CGG100 Atriclip LAA Exclusion AOD 2024 system is intended for use in patients with non-valvular AFib who are at risk of embolic events due to the condition. By isolating the LAA, the system reduces the risk of blood clots forming in the structure and subsequently traveling to the brain, causing a stroke.

The system is designed with patient safety in mind. It is compatible with various imaging modalities, including fluoroscopy, transesophageal echocardiography (TEE), and intracardiac echocardiography (ICE), allowing for accurate placement and deployment of the clip. Additionally, the system is designed to minimize the risk of complications, such as thrombus formation, device embolization, and damage to adjacent structures.

In summary, the Atricure CGG100 Atriclip LAA Exclusion AOD 2024 is a minimally invasive, clip-based system designed for the treatment of atrial fibrillation by isolating the left atrial appendage. The system consists of a self-expanding nitinol clip with a pre-attached occluder and a flexible, steerable delivery sheath. The system is intended for use in patients with non-valvular AFib who are at risk of embolic events and is designed to minimize the risk of complications.

The Atricure CGG-100 Atriclip LAAB AOD 2024 is a medical device used in Transcatheter Ablation procedures for the closure of Atrial Septal Defects (ASDs) and Patent Foramen Ovale (PFOs). This device is an alternative to traditional surgical methods for ASD and PFO closure. Here are some pros and cons of using the Atricure CGG-100 Atriclip LAAB AOD 2024:

Pros:

1. Minimally Invasive: The Atricure CGG-100 Atriclip LAAB AOD 2024 is a minimally invasive procedure, which means patients typically experience less pain, fewer complications, and a shorter hospital stay compared to traditional surgical methods.

2. Rapid Closure: The device allows for rapid closure of ASDs and PFOs, often within minutes, which can lead to quicker recovery times for patients.

3. Reduced Risk of Complications: Minimally invasive procedures, such as those using the Atricure CGG-100 Atriclip LAAB AOD 2024, have a lower risk of complications compared to surgical methods.

4. Effective: Clinical studies have shown the Atricure CGG-100 Atriclip LAAB AOD 2024 to be effective in closing ASDs and PFOs with high success rates.

Cons:

1. Cost: The Atricure CGG-100 Atriclip LAAB AOD 2024 is a more expensive option compared to traditional surgical methods for closing ASDs and PFOs.

2. Limited Size Range: The Atricure CGG-100 Atriclip LAAB AOD 2024 is only suitable for smaller ASDs and PFOs. Larger defects may require surgical intervention.

3. Training and Experience: The use of the Atricure CGG-100 Atriclip LAAB AOD 2024 requires specialized training and experience among medical personnel to ensure proper placement and closure of the device.

Conclusion:

The Atricure CGG-100 Atriclip LAAB AOD 2024 offers several advantages over traditional surgical methods for closing Atrial Septal Defects and Patent Foramen Ovale, including minimally invasive procedures, rapid closure, and reduced risk of complications. However, it also comes with a higher cost, limited size range, and the need for specialized training and experience among medical personnel.

Recommendation:

For patients with smaller Atrial Septal Defects or Patent Foramen Ovale, the Atricure CGG-100 Atriclip LAAB AOD 2024 can be an effective and less invasive alternative to traditional surgical methods. However, it is essential to consider the cost and availability of this technology, as well as the expertise of the medical team performing the procedure. Patients should consult with their healthcare providers to determine the best treatment option for their individual circumstances.

Details:

Model: CGG100. Same day shipping, if paid before 3pm. No liabilities on damaged or lost package. Type: Exclusion System.

Videos can be sent upon request. Please refer to the pictures, check. New In Open Box.

part #: cgg100 price

  • $300.00

specifications labequipi:

  • brand: Atricure
  • mpn: Cgg100
  • part type: Guide
  • unit type: Unit
  • instrument: Exclusion System
  • country/region of manufacture: United States

offer labequipi:

  • best offers: True
  • options: Ship-to-home
  • availability: In Stock
  • sold: 0
  • quantity: 3
  • started: July 11, 2025

payments labequipi:

  • credit card: Visa
  • wallet: Apple-pay
  • cash
  • other

shipping labequipi:

  • cost: $15.00
  • service: FedEx Ground or FedEx Home Delivery
  • class: Standard
  • carrier: FedEx
  • transit: 3-6 Days
  • type: Fixed

returns labequipi:

  • paid by: Seller
  • time: 30 Days
  • policy: Returns Accepted
  • method: Money back

seller labequipi:

  • # reviews: 7019
  • city: Addison, Illinois
  • rating: 100.0%

general labequipi:

  • Healthcare, Lab Dental > Handpieces Instruments > Laparoscopic Instruments
  • condition: New Open box
part type: guide, unit type: unit, instrument: exclusion system, country/region of manufacture: united states,
category: business & industrial > healthcare, lab dental > handpieces instruments > laparoscopic instruments, sku: 18788705295786611,
labequipi logo
1 offer $300.00 USD
  • New. Offer #1 priced at $300.00 + $20.00 shipping estimate = $320.00* total. +$20.00 shipping

Copyright © labequipi.com